Company LanZhou Foci Pharmaceutical Co.,Ltd.

Equities

002644

CNE1000019W4

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
7.43 CNY +1.23% Intraday chart for LanZhou Foci Pharmaceutical Co.,Ltd. +3.34% -23.79%

Business Summary

LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Company’s main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Traditional Chinese Medicine, Chinese Medicinal Materials and Protective Equipment
99.3 %
985 96.6 % 1,155 99.3 % +17.27%
Other
0.5 %
- - 5 0.5 % -
Food and Health Products
0.2 %
3 0.3 % 2 0.2 % -40.83%
Pharmaceutical Packaging Materials
0.1 %
1 0.1 % 1 0.1 % +15.48%
Nucleic Acid Testing Service
0.0 %
31 3.0 % 0 0.0 % -99.69%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
91.1 %
942 92.4 % 1,059 91.1 % +12.49%
Abroad
8.9 %
77 7.6 % 104 8.9 % +33.95%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 17-06-29
Director of Finance/CFO - 22-12-01
Director/Board Member 50 91-10-31
Director/Board Member 47 20-01-01
Investor Relations Contact - -
Corporate Officer/Principal 55 99-12-07
Corporate Officer/Principal 57 99-12-07

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 22-05-11
Director/Board Member 54 20-01-01
Corporate Officer/Principal 57 99-12-07
Chairman 58 14-05-07
Director/Board Member 52 16-04-11
Chief Executive Officer 60 17-06-29
Director/Board Member 56 20-01-01
Director/Board Member 47 20-01-01
Director/Board Member 50 91-10-31
Director/Board Member 46 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 510,657,000 173,807,625 ( 34.04 %) 0 34.04 %

Shareholders

NameEquities%Valuation
Lanzhou State-Owned Assets Supervision & Admin Commission
61.63 %
314,713,676 61.63 % 350 M ¥
Hai Jun Lu
1.743 %
8,900,531 1.743 % 10 M ¥
7,650,775 1.498 % 9 M ¥
Zhong Ou Asset Management Co., Ltd
1.498 %
7,650,775 1.498 % 9 M ¥
6,191,300 1.212 % 7 M ¥
Kuwait Investment Authority (Investment Management)
0.6993 %
3,571,120 0.6993 % 4 M ¥
3,100,400 0.6071 % 3 M ¥
Peng Yun Xu
0.4848 %
2,475,900 0.4848 % 3 M ¥
2,400,000 0.4700 % 3 M ¥
RBC Global Asset Management (Asia) Ltd.
0.3946 %
2,015,200 0.3946 % 2 M ¥

Company contact information

Lanzhou Foci Pharmaceutical Co., Ltd.

2289 Huashan Road Lanzhou New District

730000, Lanzhou

+86 93 1362 889

http://www.fczy.com
address LanZhou Foci Pharmaceutical Co.,Ltd.(002644)
  1. Stock Market
  2. Equities
  3. 002644 Stock
  4. Company LanZhou Foci Pharmaceutical Co.,Ltd.